Rise of the robots: UK pharma would gain from more automation investment says Barclays
UK drugmakers have a lot to gain from additional investment in robotic production technologies according to Barclays.
UK drugmakers have a lot to gain from additional investment in robotic production technologies according to Barclays.
Sosei’s Heptares unit has won another big pharma deal with Pfizer calling on the UK membrane protein specialist to help it identify potential drugs.
Niche technologies will differentiate CMOs looking for a slice of the steady oral dosage manufacturing industry, according to an industry report from ISR.
Clariant will build a CHF10m ($9.7m) moisture control device plant in Cuddalore, Tamil Nadu to cater for the branded and generic drugmakers operating in India.
Samsung Biologics has invested $740m to build a third facility in Korea, adding a further 180,000L of mammalian cell culture capacity.